102 related articles for article (PubMed ID: 38867080)
1. Correction: Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
Sirkisoon SR; Carpenter RL; Rimkus T; Anderson A; Harrison A; Lange AM; Jin G; Watabe K; Lo HW
Oncogene; 2024 Jun; ():. PubMed ID: 38867080
[No Abstract] [Full Text] [Related]
2. Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
Sirkisoon SR; Carpenter RL; Rimkus T; Anderson A; Harrison A; Lange AM; Jin G; Watabe K; Lo HW
Oncogene; 2018 May; 37(19):2502-2514. PubMed ID: 29449694
[TBL] [Abstract][Full Text] [Related]
3. TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
Sirkisoon SR; Carpenter RL; Rimkus T; Doheny D; Zhu D; Aguayo NR; Xing F; Chan M; Ruiz J; Metheny-Barlow LJ; Strowd R; Lin J; Regua AT; Arrigo A; Anguelov M; Pasche B; Debinski W; Watabe K; Lo HW
Oncogene; 2020 Jan; 39(1):64-78. PubMed ID: 31462709
[TBL] [Abstract][Full Text] [Related]
4. Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
Doheny D; Sirkisoon S; Carpenter RL; Aguayo NR; Regua AT; Anguelov M; Manore SG; Arrigo A; Jalboush SA; Wong GL; Yu Y; Wagner CJ; Chan M; Ruiz J; Thomas A; Strowd R; Lin J; Lo HW
Oncogene; 2020 Oct; 39(42):6589-6605. PubMed ID: 32929154
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells.
Cao X; Geradts J; Dewhirst MW; Lo HW
Oncogene; 2012 Jan; 31(1):104-15. PubMed ID: 21666711
[TBL] [Abstract][Full Text] [Related]
6. TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers.
Regua AT; Aguayo NR; Jalboush SA; Doheny DL; Manore SG; Zhu D; Wong GL; Arrigo A; Wagner CJ; Yu Y; Thomas A; Chan MD; Ruiz J; Jin G; Strowd R; Sun P; Lin J; Lo HW
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34066153
[TBL] [Abstract][Full Text] [Related]
7. The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth.
Zhu H; Carpenter RL; Han W; Lo HW
Cancer Lett; 2014 Feb; 343(1):51-61. PubMed ID: 24045042
[TBL] [Abstract][Full Text] [Related]
8. An FDA-Approved Antifungal, Ketoconazole, and Its Novel Derivative Suppress tGLI1-Mediated Breast Cancer Brain Metastasis by Inhibiting the DNA-Binding Activity of Brain Metastasis-Promoting Transcription Factor tGLI1.
Doheny D; Manore S; Sirkisoon SR; Zhu D; Aguayo NR; Harrison A; Najjar M; Anguelov M; Cox AO; Furdui CM; Watabe K; Hollis T; Thomas A; Strowd R; Lo HW
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077791
[TBL] [Abstract][Full Text] [Related]
9. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
[TBL] [Abstract][Full Text] [Related]
10. A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion.
Lo HW; Zhu H; Cao X; Aldrich A; Ali-Osman F
Cancer Res; 2009 Sep; 69(17):6790-8. PubMed ID: 19706761
[TBL] [Abstract][Full Text] [Related]
11. Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
Doheny D; Sirkisoon S; Carpenter RL; Aguayo NR; Regua AT; Anguelov M; Manore SG; Arrigo A; Jalboush SA; Wong GL; Yu Y; Wagner CJ; Chan M; Ruiz J; Thomas A; Strowd R; Lin J; Lo HW
Oncogene; 2024 Jun; 43(23):1811. PubMed ID: 38678124
[No Abstract] [Full Text] [Related]
12. The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis.
Carpenter RL; Paw I; Zhu H; Sirkisoon S; Xing F; Watabe K; Debinski W; Lo HW
Oncotarget; 2015 Sep; 6(26):22653-65. PubMed ID: 26093087
[TBL] [Abstract][Full Text] [Related]
13. The Human Glioma-Associated Oncogene Homolog 1 (GLI1) Family of Transcription Factors in Gene Regulation and Diseases.
Zhu H; Lo HW
Curr Genomics; 2010 Jun; 11(4):238-45. PubMed ID: 21119888
[TBL] [Abstract][Full Text] [Related]
14. Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.
Xu L; Kwon YJ; Frolova N; Steg AD; Yuan K; Johnson MR; Grizzle WE; Desmond RA; Frost AR
Breast Cancer Res Treat; 2010 Aug; 123(1):59-71. PubMed ID: 19902354
[TBL] [Abstract][Full Text] [Related]
15. GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation.
Liu J; Liu L; Yagüe E; Yang Q; Pan T; Zhao H; Hu Y; Zhang J
Breast Cancer Res Treat; 2019 Feb; 174(1):65-78. PubMed ID: 30450530
[TBL] [Abstract][Full Text] [Related]
16. Genomic regulation of invasion by STAT3 in triple negative breast cancer.
McDaniel JM; Varley KE; Gertz J; Savic DS; Roberts BS; Bailey SK; Shevde LA; Ramaker RC; Lasseigne BN; Kirby MK; Newberry KM; Partridge EC; Jones AL; Boone B; Levy SE; Oliver PG; Sexton KC; Grizzle WE; Forero A; Buchsbaum DJ; Cooper SJ; Myers RM
Oncotarget; 2017 Jan; 8(5):8226-8238. PubMed ID: 28030809
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog Signaling and Truncated GLI1 in Cancer.
Doheny D; Manore SG; Wong GL; Lo HW
Cells; 2020 Sep; 9(9):. PubMed ID: 32957513
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA MNX1-AS1 Promotes Progression of Triple Negative Breast Cancer by Enhancing Phosphorylation of Stat3.
Li J; Li Q; Li D; Shen Z; Zhang K; Bi Z; Li Y
Front Oncol; 2020; 10():1108. PubMed ID: 32754442
[TBL] [Abstract][Full Text] [Related]
19. Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer.
Sonnenblick A; Brohée S; Fumagalli D; Vincent D; Venet D; Ignatiadis M; Salgado R; Van den Eynden G; Rothé F; Desmedt C; Neven P; Loibl S; Denkert C; Joensuu H; Loi S; Sirtaine N; Kellokumpu-Lehtinen PL; Piccart M; Sotiriou C
BMC Med; 2015 Aug; 13():177. PubMed ID: 26234940
[TBL] [Abstract][Full Text] [Related]
20. STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits.
Chung SS; Giehl N; Wu Y; Vadgama JV
Int J Oncol; 2014 Feb; 44(2):403-11. PubMed ID: 24297508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
